Related Experiment Videos
Genomic alterations in tubular breast carcinomas
F M Waldman1, E S Hwang, J Etzell
1Cancer Center, University of California San Francisco, San Francisco, CA 94143-0808, USA.
Human Pathology
|March 7, 2001
Summary
Tubular carcinomas of the breast exhibit distinct genetic profiles, with frequent 16q loss and 1q gain. These findings suggest tubular carcinoma is a genetically unique breast cancer subtype.
Area of Science:
- Oncology
- Genetics
- Breast Cancer Research
Background:
- Tubular carcinoma is a well-differentiated breast cancer subtype with a favorable prognosis.
- Its developmental pathway and metastatic potential remain unclear.
- Understanding its genetic basis is crucial for accurate classification and treatment.
Purpose of the Study:
- To investigate the genomic alterations in pure tubular breast carcinomas.
- To determine if tubular carcinomas represent a genetically distinct group of breast cancers.
Main Methods:
- Comparative genomic hybridization (CGH) was used to analyze chromosomal changes.
- Eighteen cases of pure tubular breast carcinoma were studied.
- Genomic data were compared with existing data from mixed invasive breast cancers.
Main Results:
- Tubular carcinomas showed an average of 3.6 chromosomal alterations per case.
- The most common alterations were loss of 16q (78%) and gain of 1q (50%).
- Compared to other invasive breast cancers, tubular carcinomas had fewer overall chromosomal changes, higher 16q loss, and lower 17p loss.
Conclusions:
- Tubular carcinomas possess a distinct genetic signature.
- These findings support the classification of tubular carcinoma as a genetically unique breast cancer subtype.
- Further research into the specific genetic drivers is warranted.